BeiGene
ONC
#699
Rank
โ‚น2.403 T
Marketcap
โ‚น21,179
Share price
-3.11%
Change (1 day)
76.33%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -โ‚น524.12

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -โ‚น532.48. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-โ‚น532.48
2022-โ‚น1,66428.21%
2021-โ‚น1,298-19.96%
2020-โ‚น1,62220.81%
2019-โ‚น1,34231.52%
2018-โ‚น1,021417.57%
2017-โ‚น197.19-37.16%
2016-โ‚น313.82158.95%
2015-โ‚น121.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น85.33-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น23.04-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA